Cargando…

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

BACKGROUND: Chemoradiotherapy is the standard of care for patients with oesophageal cancer unsuitable for surgery due to the presence of co-morbidity or extent of disease, and is a standard treatment option for patients with squamous cell carcinoma of the oesophagus. Modern regimens of chemoradiothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurt, Christopher N, Nixon, Lisette S, Griffiths, Gareth O, Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N, Phillips, Ceri J, Blazeby, Jane M, Crosby, Tom D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212828/ https://www.ncbi.nlm.nih.gov/pubmed/22035459 http://dx.doi.org/10.1186/1471-2407-11-466

Ejemplares similares

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado: (2017)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
por: Adamson, Douglas, et al.
Publicado: (2021)

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
por: Mukherjee, Somnath, et al.
Publicado: (2021)

Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial
por: Adamson, Douglas, et al.
Publicado: (2014)

Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
por: Hurt, Christopher N., et al.
Publicado: (2015)

Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy
por: Wills, Lucy, et al.
Publicado: (2017)

Real-world results of definitive chemoradiation in carcinoma oesophagus: can SCOPE1 results be replicated outside trial setting?
por: Bhattacharyya, Tapesh, et al.
Publicado: (2021)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
por: Hurt, C N, et al.
Publicado: (2017)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2017)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
por: Mukherjee, Somnath, et al.
Publicado: (2013)

Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
por: Gollins, Simon, et al.
Publicado: (2017)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2015)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
por: Warren, Samantha, et al.
Publicado: (2017)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
por: Carrington, Rhys, et al.
Publicado: (2016)

A Study Comparing Acute Toxicities of Cetuximab and Cisplatin in Patients Undergoing Definitive Chemoradiation With Intensity-Modulated Radiotherapy for Locally Advanced Carcinoma Head and Neck
por: Venkateshulu, Shruthi, et al.
Publicado: (2021)

Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
por: Meira, D D, et al.
Publicado: (2009)

Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial
por: Fokas, Emmanouil, et al.
Publicado: (2016)

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
por: Cox, S, et al.
Publicado: (2016)

Fatal bleeding in a nasopharyngeal carcinoma patient after concurrent chemoradiation plus cetuximab: a case report
por: Zheng, LingYan, et al.
Publicado: (2013)

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
por: Mukherjee, Somnath, et al.
Publicado: (2023)

Carcinoma of the oesophagus
por: Seitz, J F, et al.
Publicado: (2001)

Stricture of the Œsophagus
Publicado: (1901)

Rupture of the Œsophagus
Publicado: (1900)

Rupture of Œsophagus
Publicado: (1933)

Spasm of the Œsophagus
Publicado: (1881)

Rupture of the Œsophagus
por: Colegrove, C.
Publicado: (1849)

On Polypus of the Œsophagus
Publicado: (1859)

Diverticulum of the Œsophagus
por: Clement, A. W.
Publicado: (1891)

Polypus of the Œsophagus
por: Everett, J. T.
Publicado: (1871)

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2019)

Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus
por: Kaneko, K, et al.
Publicado: (2003)

Atypical lipomatous tumour of the oesophagus
por: Smith, Alan I, et al.
Publicado: (2019)

The incidence of cancer of the oesophagus in West Kenya.
por: Ahmed, N., et al.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_l9mqth1db4qr7v8pd0pfl7hnir